Clinical Trial

Plan A Occlusion and Reversal System Feasibility Study

Name: Plan A Occlusion and Reversal System Feasibility Study — clinical trial record (NCT07361120)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.

Trial Details

NCT Number	NCT07361120
Lead Sponsor	Next Life Sciences Collaborators: Clinico Pty Ltd
Conditions	Fertility, Fertility, Male, Healthy Male Adults
Enrollment	40 participants
Start Date	2026-01
Primary Completion	2026-08 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-22